1978
Bajor et al.
N-[(5-Hexnyl-uracil-1-yl)acetyl]-N-(2-dimethoxytrityloxy-ethyl)glycine-(50-deoxy-
thymidin-50-yl)amide (16). Yield: 77%, Rf(D): 0.77; IR n [cmꢂ1] ¼ 3180 w (NH),
1716 s (as C¼O uracil), 1687 s (–NH–C¼O), 1670 s (s C¼O uracil), 1653 s (>N–
1
C¼O), 1608 w and 1510 m (aromatic), 1465 m, 1252 m, 1178 w, 1034 w; H NMR
(CDCl3): d ¼ 0.90 (3H, t, CH3 of hexynyl), 1.35–1.70 (4H, m, (CH2)2 of hexynyl),
1.88 (3H, s, 5-CH3 of T), 2.39 (2H, t, CꢁC–CH2), 2.72–2.90 (2H, m, H20ab), 3.20–3.65
(6H, m, H50ab and DMT–O–(CH2)2), 3.80 (6H, s, 2 OMe of DMT), 4.20–4.50
(3H, m, H40 and glycine CH2), 4.70–4.90 (3H, m, H30 and B–CH2), 5.32 (1H, d, 30-
OH), 5.75 (1H, t, 50-NH), 6.15 (1H, dd, H10), 6.80–7.50 (15H, 2 m, aromatic and 2
H6), 11.32–11.41 (2H, bs, 2 NH); ESI MS m=z 883.3 [M þ Li]þ, C47H52N6O11 requires
877.01. Anal. calcd for C47H52N6O11: C, 64.36; H, 5.98; N, 9.58. Found: C, 64.21; H,
6.11; N, 9.47.
General Procedure for the Phosphitylation of Chimeric Dimers. The chimeric
dimer (14, 15 or 16) was dissolved in dry CH2Cl2 (20 mL) then diisopropylammo-
nium tetrazolide (DIPAT, 1.5 mmol) and bis-diisopropylamino-2-cyanoethyl-phos-
phite (0.87 mL ¼ 3.0 mmol) were added with stirring in Ar atmosphere. The
mixture was left to stir at ambient temperature overnight then it was diluted with
CH2Cl2 (30 mL) and washed with cold, 2% (w=v) aq. Na2CO3 (2 ꢄ 20 mL) then with
brine (20 mL). The CH2Cl2 solution was dried with Na2SO4, filtered and evaporated
to dryness. The residue was dissolved in EtOAc-TEA 19:1 (5 mL) and applied to a
silica gel column made of Kieselgel 60 (0.04–0.06 mm, 70 g) which was eluted with
linear gradient of EtOAc-TEA (5%)! EtOAc-MeOH (5%)–TEA (5%) (300–
300 mL). The appropriate pure fractions were combined, evaporated and dried in
vacuo, over P2O5 to give the required 30-O-(b-cyanoethyl-N,N-diisopropyl)-phos-
phoramidites (17, 18 and 19), as white solid foams.
N-(Thymin-1-yl-acetyl)-N-(2-dimethoxytrityloxy-ethyl)glycine-(50-deoxythymidin-
50-yl)amide-30-O-(N,N-diisopropylamino-2-cyanoethyl)phosphite (17). Yield: 84%,
1
Rf(E): 0.50; H NMR (CDCl3): d ¼ 1.05–1.20 (12H, 4s, 4Me), 1.81 (3H, s, 5-Me
of T), 1.87 (3H, s, 5-Me of t), 2.20–2.52 (2H, m, H20ab), 2.60 (2H, t, CH2–O),
3.17–3.30 (2H, m, HCMe2), 3.35–3.45 (2H, m, H50ab), 3.52–3.73 (6H, m, DMT–
O–(CH2)2 and NC–CH2), 3.78 (6H, s, OMe), 4.07 and 4.18 (2H, 2s, glycine CH2),
4.44 (1H, m, H40), 4.77 and 4.90 (2H, 2s, B–CH2), 5.12 (1H, m, H30), 5.85 (1H, t,
50-NH), 6.26 (1H, dd, H10), 6.75–7.48 (15H, m, aromatic and 2 H6), 11.20–11.35
(2H, bs, 2NH) 31P NMR (CDCl3): d ¼ 148.7 and 149.0 ppm. Anal. calcd for
C51H63N8O12P: C, 60.58; H, 6.28; N, 11.08; P, 3.06. Found: C, 60.34; H, 6.46; N,
11.02; P, 2.98.
N-[(5-Propynyl-uracil-1-yl)-acetyl]-N-(2-dimethoxytrityloxy-ethyl)glycine-(50-deoxy-
thymidin-50-yl)amide-30-O-(N,N-diisopropylamino-2-cyanoethyl)phosphite (18). Yield:
60%, Rf(E): 0.55; 1H NMR (CDCl3): d ¼ 1.02–1.16 (12H, 4s, 4Me), 1.79 (3H, s, 5-Me
of T), 1.98 (3H, s, CꢁC–Me), 2.21–2.54 (2H, m, H20ab), 2.62 (2H, t, CH2–O), 3.16–
3.28 (2H, m, HCMe2), 3.30–3.48 (2H, m, H50ab), 3.53–3.73 (6H, m, DMT–O–(CH2)2
and NC–CH2), 3.80 (6H, s, OMe), 4.10 and 4.21 (2H, 2s, glycine CH2), 4.47 (1H, m,
H40), 4.79 and 4.93 (2H, 2s, B–CH2), 5.15 (1H, m, H30), 5.90 (1H, t, 50-NH), 6.28